Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Total KLA Stockholders’ Equity
Total KLA Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Stock and Capital in Excess of Par Value, Shares
Common Stock and Capital in Excess of Par Value, Amount
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Non- Controlling Interest
Beginning balance (in shares) at Jun. 30, 2020         155,461          
Beginning balance at Jun. 30, 2020 $ 2,681,010 $ (5,530) $ 2,665,424 $ (5,530)   $ 2,090,268 $ 654,930 $ (5,530) $ (79,774) $ 15,586
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 420,567   420,567       420,567      
Net income attributable to non-controlling interest (425)                 (425)
Other comprehensive income (loss) 328   328           328  
Net issuance under employee stock plans (in shares)         172          
Net issuance under employee stock plans (25,145)   (25,145)     (25,145)        
Repurchase of common stock (in shares)         (1,027)          
Repurchase of common stock (193,897)   (193,897)     (19,400) (174,497)      
Cash dividends and dividend equivalents declared (141,555)   (141,555)       (141,555)      
Stock-based compensation expense 26,992   26,992     26,992        
Ending balance (in shares) at Sep. 30, 2020         154,606          
Ending balance at Sep. 30, 2020 2,762,345   2,747,184     2,072,715 753,915   (79,446) 15,161
Beginning balance (in shares) at Jun. 30, 2020         155,461          
Beginning balance at Jun. 30, 2020 2,681,010 $ (5,530) 2,665,424 $ (5,530)   2,090,268 654,930 $ (5,530) (79,774) 15,586
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 1,445,314                  
Net income attributable to non-controlling interest (1,019)                  
Other comprehensive income (loss) 9,301                  
Repurchase of common stock (in shares)         (2,707)          
Repurchase of common stock (644,830)                  
Ending balance (in shares) at Mar. 31, 2021         153,359          
Ending balance at Mar. 31, 2021 3,112,864   3,114,856     2,115,205 1,070,124   (70,473) (1,992)
Beginning balance (in shares) at Sep. 30, 2020         154,606          
Beginning balance at Sep. 30, 2020 2,762,345   2,747,184     2,072,715 753,915   (79,446) 15,161
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 457,251   457,251       457,251      
Net income attributable to non-controlling interest (268)                 (268)
Other comprehensive income (loss) 6,742   6,742           6,742  
Net issuance under employee stock plans (in shares)         329          
Net issuance under employee stock plans 15,356   15,356     15,356        
Repurchase of common stock (in shares)         (774)          
Repurchase of common stock (177,492)   (177,492)     (10,477) (167,015)      
Cash dividends and dividend equivalents declared (140,455)   (140,455)       (140,455)      
Stock-based compensation expense 26,827   26,596     26,596       231
Ending balance (in shares) at Dec. 31, 2020         154,161          
Ending balance at Dec. 31, 2020 2,950,306   2,935,182     2,104,190 903,696   (72,704) 15,124
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 567,496   567,496       567,496      
Net income attributable to non-controlling interest (326)                 (326)
Other comprehensive income (loss) 2,231   2,231           2,231  
Net issuance under employee stock plans (in shares)         104          
Net issuance under employee stock plans (6,674)   (6,674)     (6,674)        
Repurchase of common stock (in shares)         (906)          
Repurchase of common stock (273,441)   (273,441)     (12,431) (261,010)      
Cash dividends and dividend equivalents declared (140,058)   (140,058)       (140,058)      
Stock-based compensation expense 30,327   30,120     30,120       207
Net issuance on exercise of options by non-controlling interest 127                 127
Disposal of non-controlling interest (17,124)                 (17,124)
Ending balance (in shares) at Mar. 31, 2021         153,359          
Ending balance at Mar. 31, 2021 3,112,864   3,114,856     2,115,205 1,070,124   (70,473) (1,992)
Beginning balance (in shares) at Jun. 30, 2021         152,776          
Beginning balance at Jun. 30, 2021 3,375,642   3,377,554     2,175,988 1,277,123   (75,557) (1,912)
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 1,068,417   1,068,417       1,068,417      
Net income attributable to non-controlling interest 68                 68
Other comprehensive income (loss) (2,487)   (2,487)           (2,487)  
Net issuance under employee stock plans (in shares)         160          
Net issuance under employee stock plans (46,532)   (46,532)     (46,532)        
Repurchase of common stock (in shares)         (1,190)          
Repurchase of common stock (399,677)   (399,677)     (16,966) (382,711)      
Cash dividends and dividend equivalents declared (161,561)   (161,561)       (161,561)      
Stock-based compensation expense 25,216   25,216     25,216        
Ending balance (in shares) at Sep. 30, 2021         151,746          
Ending balance at Sep. 30, 2021 3,859,086   3,860,930     2,137,706 1,801,268   (78,044) (1,844)
Beginning balance (in shares) at Jun. 30, 2021         152,776          
Beginning balance at Jun. 30, 2021 3,375,642   3,377,554     2,175,988 1,277,123   (75,557) (1,912)
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 2,516,433                  
Net income attributable to non-controlling interest 229                  
Other comprehensive income (loss) 4,024                  
Repurchase of common stock (in shares)         (3,833)          
Repurchase of common stock (1,394,217)                  
Ending balance (in shares) at Mar. 31, 2022         149,375          
Ending balance at Mar. 31, 2022 4,078,624   4,080,307     2,179,229 1,972,611   (71,533) (1,683)
Beginning balance (in shares) at Sep. 30, 2021         151,746          
Beginning balance at Sep. 30, 2021 3,859,086   3,860,930     2,137,706 1,801,268   (78,044) (1,844)
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 717,444   717,444       717,444      
Net income attributable to non-controlling interest 73                 73
Other comprehensive income (loss) 1,565   1,565           1,565  
Net issuance under employee stock plans (in shares)         205          
Net issuance under employee stock plans 31,157   31,157     31,157        
Repurchase of common stock (in shares)         (1,104)          
Repurchase of common stock (429,874)   (429,874)     (15,604) (414,270)      
Cash dividends and dividend equivalents declared (160,461)   (160,461)       (160,461)      
Stock-based compensation expense 27,766   27,766     27,766        
Ending balance (in shares) at Dec. 31, 2021         150,847          
Ending balance at Dec. 31, 2021 4,046,756   4,048,527     2,181,025 1,943,981   (76,479) (1,771)
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 730,572   730,572       730,572      
Net income attributable to non-controlling interest 88                 88
Other comprehensive income (loss) 4,946   4,946           4,946  
Net issuance under employee stock plans (in shares)         67          
Net issuance under employee stock plans (16,661)   (16,661)     (16,661)        
Repurchase of common stock (in shares)         (1,539)          
Repurchase of common stock (564,666)   (564,666)     (22,222) (542,444)      
Cash dividends and dividend equivalents declared (159,498)   (159,498)       (159,498)      
Stock-based compensation expense 37,087   37,087     37,087        
Ending balance (in shares) at Mar. 31, 2022         149,375          
Ending balance at Mar. 31, 2022 $ 4,078,624   $ 4,080,307     $ 2,179,229 $ 1,972,611   $ (71,533) $ (1,683)